Immuno-Oncology Frontiers World 2018

No other event attracts such a diverse audience of decision makers representing the key voices defining commercial success. Meet more leaders representing not just the immuno-oncology biotech sector, but the world's leading KOLs, regulators, payers, investors and big pharma. New and expanded initiatives such as the Super Plenary and CEO Forum ensure attendees of a breadth and level of influence never before seen at an event for this sector.